Literature DB >> 28272117

Altered Functional Connectivity in Sickle Cell Disease Exists at Rest and During Acute Pain Challenge.

William T Zempsky1, Michael C Stevens, James P Santanelli, Alexandra M Gaynor, Sabin Khadka.   

Abstract

OBJECTIVES: Sickle cell disease (SCD) is a chronic pain disorder in which abnormally shaped red blood cells obstruct microcirculation causing ischemia and pain. The lack of SCD responsiveness to analgesics has led many to propose that nociceptive neural systems engaged when detecting pain become sensitized, resulting in an enhancement of pain response.
METHODS: Individuals with SCD and non-SCD controls were exposed to a painful stimuli of varying intensity using a pressure algometer and underwent several neuroimaging tasks.
RESULTS: This study identified and characterized the neural correlates of possible central sensitization in SCD. We found functional connectivity abnormalities in individuals with SCD in the brain's somatosensory network, salience network, and default mode network during both an unstructured resting state and paradigm involving acute pain challenge. DISCUSSION: There was evidence for both increased and decreased connectivity which is consistent with findings in other chronic pain disorders. Preliminary evidence was found that subcortical brain regions might contribute to neurodevelopmental abnormalities in chronic pain. The results support a model in which SCD pain sensitization involves abnormally low functional integration of brain regions that make use of nociceptive information to plan movements, and hyperconnectivity of various frontal and parietal lobe regions that direct attention to or represent higher-order abstractions within circuits involved with either nocioceptive processing or detection of abnormally salient environmental stimuli.

Entities:  

Mesh:

Year:  2017        PMID: 28272117     DOI: 10.1097/AJP.0000000000000492

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  8 in total

Review 1.  Pain-measurement tools in sickle cell disease: where are we now?

Authors:  Deepika S Darbari; Amanda M Brandow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

2.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

Review 3.  State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.

Authors:  Latika Puri; Kerri A Nottage; Jane S Hankins; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

4.  Do chronic pain and comorbidities affect brain function in sickle cell patients? A systematic review of neuroimaging and treatment approaches.

Authors:  Joyce T Da Silva; Janelle E Letzen; Jennifer A Haythornthwaite; Patrick H Finan; Claudia M Campbell; David A Seminowicz
Journal:  Pain       Date:  2019-09       Impact factor: 7.926

Review 5.  Sickle cell disease chronic joint pain: Clinical assessment based on maladaptive central nervous system plasticity.

Authors:  Tiago da Silva Lopes; Samir K Ballas; Jamille Evelyn Rodrigues Souza Santana; Pedro de Melo-Carneiro; Lilian Becerra de Oliveira; Katia Nunes Sá; Larissa Conceição Dias Lopes; Wellington Dos Santos Silva; Rita Lucena; Abrahão Fontes Baptista
Journal:  Front Med (Lausanne)       Date:  2022-09-20

Review 6.  Subliminal (latent) processing of pain and its evolution to conscious awareness.

Authors:  David Borsook; Andrew M Youssef; Nadia Barakat; Christine B Sieberg; Igor Elman
Journal:  Neurosci Biobehav Rev       Date:  2018-02-21       Impact factor: 8.989

7.  Functional Connectivity Decreases with Metabolic Stress in Sickle Cell Disease.

Authors:  Melanie E Fields; Amy E Mirro; Kristin P Guilliams; Michael M Binkley; Luisa Gil Diaz; Jessica Tan; Slim Fellah; Cihat Eldeniz; Yasheng Chen; Andria L Ford; Joshua S Shimony; Allison A King; Hongyu An; Christopher D Smyser; Jin-Moo Lee
Journal:  Ann Neurol       Date:  2020-09-16       Impact factor: 10.422

8.  MRI detection of brain abnormality in sickle cell disease.

Authors:  Hanne Stotesbury; Jamie Michelle Kawadler; Dawn Elizabeth Saunders; Fenella Jane Kirkham
Journal:  Expert Rev Hematol       Date:  2021-06-07       Impact factor: 2.929

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.